CooperCompanies to Participate in Upcoming Investor Conferences
CooperCompanies (Nasdaq: COO), a leading global medical device company, has announced its participation in two upcoming investor conferences.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
CooperCompanies (Nasdaq: COO), a leading global medical device company, has announced its participation in two upcoming investor conferences. The company will be represented by Al White, President & Chief Executive Officer, in fireside chats at both events:
1. 2024 Wells Fargo Healthcare Conference on Wednesday, September 4, 2024, at 3:45 pm ET
2. Morgan Stanley Annual Global Healthcare Conference on Thursday, September 5, 2024, at 1:50 pm ET
Investors and interested parties can access webcasts of both sessions through the CooperCompanies' website at http://investor.coopercos.com.
Details
News Market Reaction – COO
The recorded move for COO in the trading session of this news was +0.04%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN RAMON, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced its participation in the following upcoming investor conferences:
2024 Wells Fargo Healthcare Conference
Wednesday, September 4, 2024, at 3:45 pm ET
Al White, President & Chief Executive Officer, will represent the Company in a fireside chat
Morgan Stanley Annual Global Healthcare Conference
Thursday, September 5, 2024, at 1:50 pm ET
Al White, President & Chief Executive Officer, will represent the Company in a fireside chat
A webcast of each session will be available to investors and other interested parties by accessing the CooperCompanies’ website at http://investor.coopercos.com.
About CooperCompanies
CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on improving lives one person at a time. The Company operates through two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, improving the vision of millions of people every day. CooperSurgical is a leading fertility and women’s health company dedicated to assisting women, babies and families at the healthcare moments that matter most. Headquartered in San Ramon, CA, CooperCompanies (“Cooper”) has a workforce of more than 15,000 with products sold in over 130 countries. For more information, please visit www.coopercos.com.
Contact:
Kim Duncan
Vice President, Investor Relations and Risk Management
925-460-3663
ir@cooperco.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.